First human trial of Boston Scientific's ablation device closes

05/7/2013 | (Boston)

Boston Scientific has concluded the first human study involving its IntellaTip MiFi XP system, an ablation catheter designed to treat patients with heart arrhythmia. The device could be the first among a series of ablation catheters that the company intends to launch in the next few years. Boston Scientific is investing in electrophysiology as a "key growth area."

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC